You are here: Home

SURVMARK-2 will produce high impact cancer survival, incidence and mortality comparisons as part of the International Cancer Benchmarking Partnership (ICBP). The ICBP is a unique and innovative collaboration that brings together clinicians, policy-makers, researchers, and cancer data experts. It aims to measure international differences in cancer survival, and crucially, to identify factors that might be driving these differences.

The SURVMARK-2 project was launched in July 2016 and is set to be completed in early 2020.


A SURVMARK-2 Meeting is organized during the 39th Annual Conference of the International Association of Cancer Registries on 18 October 2017 at 13.00 in room Quest - all SURVMARK-2 colleagues and partners are welcome to join.
Call for expertise transfer fellowship applications will soon be launched
Kick-off meeting of the executive group held in London on 27/28 March 2017. View photo
SURVMARK-2 call for data launched in July 2016 – 20 jurisdictions from 6 countries participating